#BEGIN_DRUGCARD DB04099

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
18304

# Chemical_Formula:
C21H27N6O15P2

# Chemical_IUPAC_Name:
1-[(2R,3R,4R,5S)-5-[({[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carboxy-1$l^{5}-pyridin-1-ylium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Deamido-Nad+

# HET_ID:
DND

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C21H26N6O15P2/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(31)14(29)11(41-20)6-39-44(36,37)42-43(34,35)38-5-10-13(28)15(30)19(40-10)26-3-1-2-9(4-26)21(32)33/h1-4,7-8,10-11,13-16,19-20,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15+,16+,19+,20+/m0/s1

# InChI_Key:
InChIKey=SENPVEZBRZQVST-AAIUHBJKSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4099

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
665.4178

# Molecular_Weight_Mono:
665.100962248

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1EE1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.89

# Predicted_LogS:
-2.6

# Predicted_Water_Solubility:
1.88e+00 g/l

# Primary_Accession_No:
DB04099

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6336819

# PubChem_Substance_ID:
46507165

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01234

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H]2O[C@H]([C@H](O)[C@H]2O)[N+]2=CC=CC(=C2)C(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:57 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M15811

# Drug_Target_1_GenBank_ID_Protein:
143279

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nadE

# Drug_Target_1_Gene_Sequence:
>819 bp
ATGAGCATGCAGGAAAAGATTATGCGTGAGTTACATGTGAAGCCCTCAATTGATCCAAAG
CAAGAAATTGAGGACCGAGTCAATTTTTTAAAACAATATGTAAAGAAAACCGGTGCTAAA
GGCTTTGTATTGGGAATCAGCGGGGGCCAGGATTCAACACTTGCGGGAAGACTCGCTCAG
CTTGCGGTGGAGAGCATTCGCGAGGAGGGCGGAGACGCTCAATTTATCGCGGTCCGTCTT
CCGCATGGCACACAGCAGGATGAAGACGATGCCCAGCTTGCTTTGAAGTTTATTAAGCCG
GATAAATCATGGAAGTTTGATATTAAATCGACAGTCAGCGCTTTTTCTGATCAGTATCAG
CAGGAAACAGGCGATCAGCTGACGGACTTTAATAAAGGAAACGTAAAAGCAAGAACAAGA
ATGATCGCGCAATACGCGATCGGCGGCCAGGAAGGTCTTCTTGTGTTAGGAACAGACCAT
GCTGCTGAAGCAGTGACTGGTTTCTTTACGAAGTACGGTGACGGCGGAGCAGACCTCCTG
CCGCTGACAGGCTTGACGAAGCGCCAGGGAAGAACCTTGCTGAAAGAGCTGGGTGCACCG
GAACGCTTATACTTAAAAGAACCGACTGCCGATCTGCTCGACGAAAAACCGCAGCAGTCG
GATGAAACAGAGCTTGGCATTTCCTACGACGAGATTGACGATTATCTCGAAGGAAAAGAA
GTATCAGCGAAAGTATCAGAAGCGCTGGAAAAACGCTACAGCATGACTGAACATAAACGC
CAGGTTCCGGCGTCTATGTTTGATGACTGGTGGAAATAA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
11375500	Devedjiev Y, Symersky J, Singh R, Jedrzejas M, Brouillette C, Brouillette W, Muccio D, Chattopadhyay D, DeLucas L: Stabilization of active-site loops in NH3-dependent NAD+ synthetase from Bacillus subtilis. Acta Crystallogr D Biol Crystallogr. 2001 Jun;57(Pt 6):806-12. Epub 2001 May 25.
12077433	Symersky J, Devedjiev Y, Moore K, Brouillette C, DeLucas L: NH3-dependent NAD+ synthetase from Bacillus subtilis at 1 A resolution. Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1138-46. Epub 2002 Jun 20.
1556067	Mitchell C, Morris PW, Vary JC: Identification of proteins phosphorylated by ATP during sporulation of Bacillus subtilis. J Bacteriol. 1992 Apr;174(8):2474-7.
2118513	Albertini AM, Galizzi A: The Bacillus subtilis outB gene is highly homologous to an Escherichia coli ntr-like gene. J Bacteriol. 1990 Sep;172(9):5482-5.
2435704	Albertini AM, Caramori T, Henner D, Ferrari E, Galizzi A: Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J Bacteriol. 1987 Apr;169(4):1480-4.
7890752	Nessi C, Albertini AM, Speranza ML, Galizzi A: The outB gene of Bacillus subtilis codes for NAD synthetase. J Biol Chem. 1995 Mar 17;270(11):6181-5.
8895556	Rizzi M, Nessi C, Mattevi A, Coda A, Bolognesi M, Galizzi A: Crystal structure of NH3-dependent NAD+ synthetase from Bacillus subtilis. EMBO J. 1996 Oct 1;15(19):5125-34.
8969502	Yamane K, Kumano M, Kurita K: The 25 degrees-36 degrees region of the Bacillus subtilis chromosome: determination of the sequence of a 146 kb segment and identification of 113 genes. Microbiology. 1996 Nov;142 ( Pt 11):3047-56.
9298659	Antelmann H, Bernhardt J, Schmid R, Mach H, Volker U, Hecker M: First steps from a two-dimensional protein index towards a response-regulation map for Bacillus subtilis. Electrophoresis. 1997 Aug;18(8):1451-63.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9753692	Rizzi M, Bolognesi M, Coda A: A novel deamido-NAD+-binding site revealed by the trapped NAD-adenylate intermediate in the NAD+ synthetase structure. Structure. 1998 Sep 15;6(9):1129-40.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2910

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
30396

# Drug_Target_1_Name:
NH(3)-dependent NAD(+) synthetase

# Drug_Target_1_Number_of_Residues:
272

# Drug_Target_1_PDB_ID:
1IH8

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02540	NAD_synthase

# Drug_Target_1_Protein_Sequence:
>NH(3)-dependent NAD(+) synthetase
MSMQEKIMRELHVKPSIDPKQEIEDRVNFLKQYVKKTGAKGFVLGISGGQDSTLAGRLAQ
LAVESIREEGGDAQFIAVRLPHGTQQDEDDAQLALKFIKPDKSWKFDIKSTVSAFSDQYQ
QETGDQLTDFNKGNVKARTRMIAQYAIGGQEGLLVLGTDHAAEAVTGFFTKYGDGGADLL
PLTGLTKRQGRTLLKELGAPERLYLKEPTADLLDEKPQQSDETELGISYDEIDDYLEGKE
VSAKVSEALEKRYSMTEHKRQVPASMFDDWWK

# Drug_Target_1_Reaction:
ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes a key step in NAD biosynthesis, transforming deamido-NAD into NAD by a two-step reaction

# Drug_Target_1_SwissProt_ID:
P08164

# Drug_Target_1_SwissProt_Name:
NADE_BACSU

# Drug_Target_1_Synonyms:
EC 6.3.1.5
GSP38
General stress protein 38
Spore outgrowth factor B
Sporulation protein outB

# Drug_Target_1_Theoretical_pI:
4.83

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Nucleus

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
NMNAT1

# Drug_Target_2_GenBank_ID_Gene:
AF314163

# Drug_Target_2_GenBank_ID_Protein:
11245478

# Drug_Target_2_GeneCard_ID:
NMNAT1

# Drug_Target_2_Gene_Name:
NMNAT1

# Drug_Target_2_Gene_Sequence:
>840 bp
ATGGAAAATTCCGAGAAGACTGAAGTGGTTCTCCTTGCTTGTGGTTCATTCAATCCCATC
ACCAACATGCACCTCAGGTTGTTTGAGCTGGCCAAGGACTACATGAATGGAACAGGAAGG
TACACAGTTGTCAAAGGCATCATCTCTCCTGTTGGTGATGCCTACAAGAAGAAAGGACTC
ATTCCTGCCTATCACCGGGTCATCATGGCAGAACTTGCTACCAAGAATTCTAAATGGGTG
GAAGTTGATACATGGGAAAGTCTTCAGAAGGAGTGGAAAGAGACTCTGAAGGTGCTAAGA
CACCATCAAGAGAAATTGGAGGCTAGTGACTGTGATCACCAGCAGAACTCACCTACTCTA
GAAAGGCCTGGAAGGAAGAGGAAGTGGACTGAAACACAAGATTCTAGTCAAAAGAAATCC
CTAGAGCCAAAAACAAAAGCTGTGCCAAAGGTCAAGCTGCTGTGTGGGGCAGATTTATTG
GAGTCCTTTGCTGTTCCCAATTTGTGGAAGAGTGAAGACATCACCCAAATCGTGGCCAAC
TATGGGCTCATATGTGTTACTCGGGCTGGAAATGATGCTCAGAAGTTTATCTATGAATCG
GATGTGCTGTGGAAACACCGGAGCAACATTCACGTGGTGAATGAATGGATCGCTAATGAC
ATCTCATCCACAAAAATCCGGAGAGCCCTCAGAAGGGGCCAGAGCATTCGCTACTTGGTA
CCAGATCTTGTCCAAGAATACATTGAAAAGCATAATTTGTACAGCTCTGAGAGTGAAGAC
AGGAATGCTGGGGTCATCCTGGCCCCTTTGCAGAGAAACACTGCAGAAGCTAAGACATAG

# Drug_Target_2_General_Function:
Coenzyme transport and metabolism

# Drug_Target_2_General_References:
11248244	Schweiger M, Hennig K, Lerner F, Niere M, Hirsch-Kauffmann M, Specht T, Weise C, Oei SL, Ziegler M: Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett. 2001 Mar 9;492(1-2):95-100.
11751893	Garavaglia S, D'Angelo I, Emanuelli M, Carnevali F, Pierella F, Magni G, Rizzi M: Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J Biol Chem. 2002 Mar 8;277(10):8524-30. Epub 2001 Dec 19.
11891043	Fernando FS, Conforti L, Tosi S, Smith AD, Coleman MP: Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouse. Gene. 2002 Feb 6;284(1-2):23-9.

# Drug_Target_2_HGNC_ID:
HGNC:17877

# Drug_Target_2_HPRD_ID:
16369

# Drug_Target_2_ID:
3296

# Drug_Target_2_Locus:
1p32-p35

# Drug_Target_2_Molecular_Weight:
31933

# Drug_Target_2_Name:
Nicotinamide mononucleotide adenylyltransferase 1

# Drug_Target_2_Number_of_Residues:
279

# Drug_Target_2_PDB_ID:
1KQO

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_2_Protein_Sequence:
>Nicotinamide mononucleotide adenylyltransferase 1
MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGL
IPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTL
ERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVAN
YGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLV
PDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT

# Drug_Target_2_Reaction:
ATP + nicotinamide ribonucleotide = diphosphate + NAD+

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + nicotinamide ribonucleotide = diphosphate + NAD(+)

# Drug_Target_2_SwissProt_ID:
Q9HAN9

# Drug_Target_2_SwissProt_Name:
NMNA1_HUMAN

# Drug_Target_2_Synonyms:
EC 2.7.7.1
NMN adenylyltransferase 1

# Drug_Target_2_Theoretical_pI:
9.24

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
D84432

# Drug_Target_3_GenBank_ID_Protein:
1303791

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
nadD

# Drug_Target_3_Gene_Sequence:
>570 bp
ATGAAGAAAATCGGAATTTTCGGAGGCACGTTTGACCCTCCGCATAATGGTCACCTCTTA
ATGGCGAATGAGGTGCTGTACCAGGCGGGGCTTGATGAAATTTGGTTTATGCCTAATCAA
ATTCCGCCGCATAAACAGAACGAAGACTATACCGACAGCTTTCATCGCGTGGAAATGCTA
AAGCTTGCAATTCAATCTAATCCGTCCTTTAAGCTGGAGCTTGTTGAAATGGAAAGAGAA
GGGCCATCATATACCTTTGATACCGTTTCTTTACTGAAGCAGCGTTATCCAAATGATCAG
CTGTTCTTTATTATCGGCGCTGATATGATTGAATATTTGCCGAAATGGTATAAGCTGGAC
GAGCTGCTGAACCTCATTCAATTTATTGGAGTAAAGCGCCCCGGTTTTCATGTTGAAACC
CCTTATCCGCTTCTCTTTGCAGACGTTCCGGAATTTGAGGTATCATCAACTATGATAAGG
GAACGGTTTAAAAGCAAGAAGCCCACTGACTACTTAATCCCTGATAAAGTGAAGAAGTAT
GTAGAGGAGAATGGTTTATATGAATCGTGA

# Drug_Target_3_General_Function:
Coenzyme transport and metabolism

# Drug_Target_3_General_References:
11704676	Olland AM, Underwood KW, Czerwinski RM, Lo MC, Aulabaugh A, Bard J, Stahl ML, Somers WS, Sullivan FX, Chopra R: Identification, characterization, and crystal structure of Bacillus subtilis nicotinic acid mononucleotide adenylyltransferase. J Biol Chem. 2002 Feb 1;277(5):3698-707. Epub 2001 Nov 9.
8969508	Mizuno M, Masuda S, Takemaru K, Hosono S, Sato T, Takeuchi M, Kobayashi Y: Systematic sequencing of the 283 kb 210 degrees-232 degrees region of the Bacillus subtilis genome containing the skin element and many sporulation genes. Microbiology. 1996 Nov;142 ( Pt 11):3103-11.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3087

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
22157

# Drug_Target_3_Name:
Nicotinate-nucleotide adenylyltransferase

# Drug_Target_3_Number_of_Residues:
189

# Drug_Target_3_PDB_ID:
1KAQ

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_3_Protein_Sequence:
>Nicotinate-nucleotide adenylyltransferase
MKKIGIFGGTFDPPHNGHLLMANEVLYQAGLDEIWFMPNQIPPHKQNEDYTDSFHRVEML
KLAIQSNPSFKLELVEMEREGPSYTFDTVSLLKQRYPNDQLFFIIGADMIEYLPKWYKLD
ELLNLIQFIGVKRPGFHVETPYPLLFADVPEFEVSSTMIRERFKSKKPTDYLIPDKVKKY
VEENGLYES

# Drug_Target_3_Reaction:
ATP + nicotinate ribonucleotide = diphosphate + deamido-NAD+

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the reversible adenylation of nicotinate mononucleotide (NaMN) to nicotinic acid adenine dinucleotide (NaAD)

# Drug_Target_3_SwissProt_ID:
P54455

# Drug_Target_3_SwissProt_Name:
NADD_BACSU

# Drug_Target_3_Synonyms:
Deamido- NAD(+) pyrophosphorylase
Deamido-NAD(+) diphosphorylase
EC 2.7.7.18
NaMN adenylyltransferase
Nicotinate mononucleotide adenylyltransferase

# Drug_Target_3_Theoretical_pI:
5.11

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Nucleus (Probable)

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
NMNAT3

# Drug_Target_4_GenBank_ID_Gene:
AF345564

# Drug_Target_4_GenBank_ID_Protein:
14029540

# Drug_Target_4_GeneCard_ID:
NMNAT3

# Drug_Target_4_Gene_Name:
NMNAT3

# Drug_Target_4_Gene_Sequence:
>759 bp
ATGAAGAGCCGAATACCTGTGGTGCTCCTGGCCTGTGGCTCCTTTAACCCCATCACCAAC
ATGCACCTGCGCATGTTTGAGGTGGCCAGAGATCACCTACACCAAACAGGAATGTACCAG
GTCATCCAGGGTATCATCTCTCCTGTCAACGACACCTATGGGAAGAAAGACCTCGCAGCT
TCTCATCACCGAGTGGCCATGGCCCGGCTGGCCCTGCAGACATCCGACTGGATCCGGGTG
GACCCTTGGGAGAGTGAGCAGGCACAGTGGATGGAGACAGTGAAGGTGCTGAGGCATCAT
CACAGCAAACTGCTCAGATCTCCACCCCAGATGGAAGGCCCAGACCATGGCAAGGCACTC
TTCTCGACCCCTGCAGCTGTGCCTGAGCTGAAGCTTCTCTGTGGGGCAGACGTCTTGAAG
ACCTTCCAGACCCCCAACCTCTGGAAGGATGCGCACATCCAGGAAATAGTGGAGAAGTTT
GGCTTGGTGTGCGTGGGCCGAGTAAGTCACGACCCAAAAGGTTACATCGCAGAATCTCCC
ATCCTACGGATGCACCAGCACAACATTCACCTGGCCAAGGAGCCTGTGCAGAATGAGATC
AGTGCCACATACATCAGGCGAGCCTTGGGCCAAGGGCAGAGCGTAAAGTACCTGATTCCC
GATGCTGTCATCACGTACATCAAGGACCATGGCCTCTACACCAAGGGCAGTACCTGGAAA
GGCAAAAGCACCCAGAGCACTGAGGGCAAGACAAGCTAG

# Drug_Target_4_General_Function:
Coenzyme transport and metabolism

# Drug_Target_4_General_References:
Not Available

# Drug_Target_4_HGNC_ID:
HGNC:20989

# Drug_Target_4_HPRD_ID:
16370

# Drug_Target_4_ID:
3333

# Drug_Target_4_Locus:
3q23

# Drug_Target_4_Molecular_Weight:
28322

# Drug_Target_4_Name:
Nicotinamide mononucleotide adenylyltransferase 3

# Drug_Target_4_Number_of_Residues:
252

# Drug_Target_4_PDB_ID:
1NUU

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_4_Protein_Sequence:
>Nicotinamide mononucleotide adenylyltransferase 3
MKSRIPVVLLACGSFNPITNMHLRMFEVARDHLHQTGMYQVIQGIISPVNDTYGKKDLAA
SHHRVAMARLALQTSDWIRVDPWESEQAQWMETVKVLRHHHSKLLRSPPQMEGPDHGKAL
FSTPAAVPELKLLCGADVLKTFQTPNLWKDAHIQEIVEKFGLVCVGRVGHDPKGYIAESP
ILRMHQHNIHLAKEPVQNEISATYIRRALGQGQSVKYLIPDAVITYIKDHGLYTKGSTWK
GKSTQSTEGKTS

# Drug_Target_4_Reaction:
ATP + nicotinamide ribonucleotide = diphosphate + NAD+

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
ATP + nicotinamide ribonucleotide = diphosphate + NAD(+)

# Drug_Target_4_SwissProt_ID:
Q96T66

# Drug_Target_4_SwissProt_Name:
NMNA3_HUMAN

# Drug_Target_4_Synonyms:
EC 2.7.7.1
NMN adenylyltransferase 3

# Drug_Target_4_Theoretical_pI:
9.69

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AE000511

# Drug_Target_5_GenBank_ID_Protein:
2313426

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
nadE

# Drug_Target_5_Gene_Sequence:
>783 bp
TCATTCAGGGTTAAATCGTTTGGCGATGGCGGGTAATTCTAATTTAAAAGCGTTTTTTTG
GATACGGCTTGTGATGTTTTTCACTAAAATTTCATCATAGCCTAATTGAGCGAGCGTTTC
TGTATCAATGGGCTTTGTTTGAAACAACGCTTCAATATCCTTCAATAAAGGATCGATCAC
GCTATAAGGATAGCCCAAATCTTTTTCATCGCTTTGCCCCACAAATAAATCTGCGCTAGG
GGGCTTATTTAAAATCTTTTTAGGGATATTTAAACGGCGAGCGAGTTCATAAACTTCGGT
TTTAAATAATTCCCCAATCGGGTTAATCGCGCACGCCAAATCCCCAAATAAAGTGCCATA
GCCTAGCATTCTTTCGCTTTTATTGCTCGTGCCAATGACTAAAGAATCGCTTTTTAAAGA
ATAATCGTATAAAAAAGCCATGCGCAATCTTGCGCAAAAATTCCCCTTCCTAGTAAGGCT
TGCGTCTTTAAAGTGAGAGCTAAAGATGGCGTCATAGGGAGCGATAGAATATTCTGTATA
AGGGATAGAAAATTTTTCGCACAAATTTAGGGCGTCTGTTTTATTTTCTGGCATAGAGAC
TGAAGAGGGCATTAAAAGGGCATGAGCGTTTTCTTTAAAAACTTTTTGACACAGCACCCC
AACGACCGCGCTATCTAGCCCCCCGCTCAGCCCGTAAACGACTTTTTTAAAGCCGCGTTT
TTGCACTTCTTTTTCTAAAAAATCGCATAAATAAACGATGAGTTTTTGGTAATCTTTTTG
CAT

# Drug_Target_5_General_Function:
Coenzyme transport and metabolism

# Drug_Target_5_General_References:
9252185	Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539-47.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
3217

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
29269

# Drug_Target_5_Name:
NH(3)-dependent NAD(+) synthetase

# Drug_Target_5_Number_of_Residues:
260

# Drug_Target_5_PDB_ID:
1XNH

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF02540	NAD_synthase

# Drug_Target_5_Protein_Sequence:
>NH(3)-dependent NAD(+) synthetase
MQKDYQKLIVYLCDFLEKEVQKRGFKKVVYGLSGGLDSAVVGVLCQKVFKENAHALLMPS
SVSMPENKTDALNLCEKFSIPYTEYSIAPYDAIFSSHFKDASLTRKGNFCARLRMAFLYD
YSLKSDSLVIGTSNKSERMLGYGTLFGDLACAINPIGELFKTEVYELARRLNIPKKILNK
PPSADLFVGQSDEKDLGYPYSVIDPLLKDIEALFQTKPIDTETLAQLGYDEILVKNITSR
IQKNAFKLELPAIAKRFNPE

# Drug_Target_5_Reaction:
ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
ATP + deamido-NAD(+) + NH(3) = AMP + diphosphate + NAD(+)

# Drug_Target_5_SwissProt_ID:
O25096

# Drug_Target_5_SwissProt_Name:
NADE_HELPY

# Drug_Target_5_Synonyms:
EC 6.3.1.5

# Drug_Target_5_Theoretical_pI:
8.16

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
M15328

# Drug_Target_6_GenBank_ID_Protein:
146974

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
nadE

# Drug_Target_6_Gene_Sequence:
>825 bp
ATGACATTGCAACAACAAATAATAAAGGCGCTGGGCGAAAACCGCAGATTAATGCTGAAG
AGGAAATTCGTCGTAGTGTCGATTTCTGAAAGCTACCTGCAAACTTATCCGTTCATTAAA
TCACTGGTGCTCGGGATCAGCGGCGGTCAGGACTCCACGCTTGCCGGAAAGCTGTGCCAG
ATGGCGATTAATGAGCTGCGCCTGGAAACCGGCAACGAATCACTGCAATTTATTGCCGTA
CGCCTGCCCTATGGTGTTCAGGCCGACGAACAAGATTGCCAGGATGCCATTGCCTTTATT
CAACCGGATCGCGTATTAACCGTTAATATCAAGGGCGCGGTATTGGCCAGCGAACAGGCA
TTGCGGGAAGCAGGCATTGAACTGAGCGATTTTGTCCGTGGCAATGAAAAAGCGCGTGAG
CGGATGAAAGCACAATATAGCATTGCGGGTATGACCAGCGGTGTCGTGGTGGGCACCGAT
CATGCAGCAGAAGCCATTACCGGATTCTTCACTAAATATGGTGACGGCGGTACGGACATT
AATCCGCTGTATCGTCTCAACAAACGTCAGGGTAAACAGTTACTGGCGGCATTAGCTTGC
CCGGAACACCTTTATAAGAAAGCGCCAACGGCCGATCTGGAAGATGATCGCCCTTCTCTG
CCAGATGAAGTGGCACTCGGCGTGACCTATGACAATATCGACGACTATCTGGAAGGGAAA
AACGTACCTCAACAGGTCGCCAGAACAATAGAGAACTGGTATCTGAAAACCGAACATAAA
CGCCGTCCGCCAATTACCGTTTTCGATGATTTCTGGAAAAAGTAA

# Drug_Target_6_General_Function:
Coenzyme transport and metabolism

# Drug_Target_6_General_References:
1512214	Willison JC: An essential gene (efg) located at 38.1 minutes on the Escherichia coli chromosome. J Bacteriol. 1992 Sep;174(17):5765-6.
3025172	Allibert P, Willison JC, Vignais PM: Complementation of nitrogen-regulatory (ntr-like) mutations in Rhodobacter capsulatus by an Escherichia coli gene: cloning and sequencing of the gene and characterization of the gene product. J Bacteriol. 1987 Jan;169(1):260-71.
8195100	Willison JC, Tissot G: The Escherichia coli efg gene and the Rhodobacter capsulatus adgA gene code for NH3-dependent NAD synthetase. J Bacteriol. 1994 Jun;176(11):3400-2.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2434

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
30637

# Drug_Target_6_Name:
NH(3)-dependent NAD(+) synthetase

# Drug_Target_6_Number_of_Residues:
275

# Drug_Target_6_PDB_ID:
1WXI

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF02540	NAD_synthase

# Drug_Target_6_Protein_Sequence:
>NH(3)-dependent NAD(+) synthetase
MTLQQQIIKALGAKPQINAEEEIRRSVDFLKSYLQTYPFIKSLVLGISGGQDSTLAGKLC
QMAINELRLETGNESLQFIAVRLPYGVQADEQDCQDAIAFIQPDRVLTVNIKGAVLASEQ
ALREAGIELSDFVRGNEKARERMKAQYSIAGMTSGVVVGTDHAAEAITGFFTKYGDGGTD
INPLYRLNKRQGKQLLAALACPEHLYKKAPTADLEDDRPSLPDEVALGVTYDNIDDYLEG
KNVPQQVARTIENWYLKTEHKRRPPITVFDDFWKK

# Drug_Target_6_Reaction:
ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Catalyzes a key step in NAD biosynthesis, transforming deamido-NAD into NAD by a two-step reaction

# Drug_Target_6_SwissProt_ID:
P18843

# Drug_Target_6_SwissProt_Name:
NADE_ECOLI

# Drug_Target_6_Synonyms:
EC 6.3.1.5
NADS
Nicotinamide adenine dinucleotide synthetase
Nitrogen-regulatory protein

# Drug_Target_6_Theoretical_pI:
5.24

# Drug_Target_6_Transmembrane_Regions:
None

#END_DRUGCARD DB04099
